USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity
11-Dec-2020
North America
Market Research
K56B-01-00-00-00
HC03364-NA-MT_25029
The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry.
The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recent COVID-19 pandemic. Clinical laboratories and manufacturers have been vying to develop SARS-Cov-2 assays to serve the rising demand for testing. In these uncertain times, mergers, acquisitions, and partnerships have seen a considerable dip as compared with the previous year.
The US government and healthcare agencies are supporting telehealth and innovative and clinically vetted direct-to-consumer diagnostic testing services. Partnerships with digital vendors and automation companies are expected to empower core diagnostic companies with Internet of Things (IoT), cloud, and Big Data capabilities. Given these trends, it is important to understand the market dynamics to remain competitive and successful in the in vitro diagnostics market.
This report offers insightful analysis in the form of key growth opportunities that center on the use of serological testing, unmet testing needs for neurodegenerative disorders, process flow improvement through IoT technologies, and the opportunity to include direct-to-consumer capabilities in business models.
Research Highlights
• Market drivers and restraints
• Recent product trends and business updates from the US market
• Growth opportunities
• Strategic imperatives
Author: Amol Dilip Jadhav
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the US In Vitro Diagnostics Clinical Chemistry and Immunoassay Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Drivers
Growth Restraints
Merger, Acquisition, and Partnership Activities
Select Product-related Activities
Select Product-related Activities (continued)
Growth Opportunity 1: Serology Assays for COVID-19 Diagnosis
Growth Opportunity 1: Serology Assays for COVID-19 Diagnosis (continued)
Growth Opportunity 2: Biomarkers for Alzheimer’s Disease Diagnosis
Growth Opportunity 2: Biomarkers for Alzheimer’s Disease Diagnosis (continued)
Growth Opportunity 3: IoT for Optimizing Process Flow
Growth Opportunity 3: IoT for Optimizing Process Flow (continued)
Growth Opportunity 4: Direct-to-Consumer Testing Services
Growth Opportunity 4: Direct-to-Consumer Testing Services (continued)
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Highlights
• Market drivers and restraints
• Recent product trends and business updates from the US market
• Growth opportunities
• Strategic imperatives
Author: Amol Dilip Jadhav
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Amol Dilip Jadhav |
| Industries | Healthcare |
| WIP Number | K56B-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9562-B1,9627-B1 |